Seagen Inc.
NASDAQ:SGEN
Overview | Financials
Company Name | Seagen Inc. |
Symbol | SGEN |
Currency | USD |
Price | 228.74 |
Market Cap | 43,154,776,450 |
Dividend Yield | 0% |
52-week-range | 126.47 - 228.96 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. David R. Epstein B.Sc., M.B.A. |
Website | https://www.seagen.com |
An error occurred while fetching data.
About Seagen Inc.
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD